About Us

what we do

We enable biological engineering at a genome-scale

We provide our partners with groundbreaking synthetic DNA and cell engineering services to investigate novel therapeutics, develop more sustainable products, and conduct otherwise unapproachable scientific research.
Neochromosome is uniquely suited to accelerate this work. Our first-in-class capabilities were developed to design, build, and test the world’s first fully synthetic eukaryotic cells. Today, we offer our services and platform — from highly automated synthesis of complex DNA to de novo design, synthesis, and delivery of chromosomes – to researchers and organizations around the world.
Neo is a subsidiary of Opentrons Labworks. Neo leverages Opentrons’ robotics and automation for its world class genome foundry.

Our Team

Neo leadership and advisors bring together industry-leading expertise in genome-scale engineering approaches and therapeutic technologies.

Leslie Mitchell, PhD
Leslie Mitchell, PhD

GM & CEO

Gregg McConnell
Gregg McConnell

Chief Business Officer

Steven Riedmuller
Steven Riedmuller

VP Commercial Operations

Alfie Umbhau
Alfie Umbhau

VP Product

John Anderson, PhD
John Anderson, PhD

VP Software

Albert Serra Cardona, PhD
Albert Serra Cardona, PhD

Microbial Engineering Team Lead

Akil Hamza, PhD
Akil Hamza, PhD

Foundry Team Lead

Megan Hogan, PhD
Megan Hogan, PhD

Mammalian Engineering Team Lead

Jeff Spencer, PhD
Jeff Spencer, PhD

Protein Engineering Team Lead

Jon Brennan-Badal
Jon Brennan-Badal

CEO, Opentrons Labworks

Myrtle Potter
Myrtle Potter

Board Chair, Opentrons Labworks

Robert Langer, ScD
Robert Langer, ScD

Chair, Scientific Advisory Board

Vinod Khosla
Vinod Khosla

Advisor, Opentrons Labworks

Joel Bader, PhD
Joel Bader, PhD

Co-Founder & Advisor

Jef Boeke, PhD
Jef Boeke, PhD

Co-Founder & Advisor

Careers



https://www.cigna.com/legal/compliance/machine-readable-files

This link leads to the machine-readable files that are made available in response to the federal Transparency in Coverage Rule and includes negotiated service rates and out-of-network allowed amounts between health plans and healthcare providers. The machine readable files are formatted to allow researchers, regulators, and application developers to more easily access and analyze data.

LEARN MORE

Get in touch to learn more

Name